As a Harvard and NYU-educated, board-certified plastic surgeon, Dr. Rapaport has a track record of over 24 years of achieving exquisite results for his clients, and is dedicated to providing the most innovative and groundbreaking new treatments on the market. He is joined by Dr. Darren Smith, another experienced surgeon in body contouring and other minimally/non-invasive treatments. At Coolspa, each patient receives a customized, one-on-one consultation and treatment that targets their unique trouble zones. This personalized attention coupled with expert skill and artistry is the reason why Coolspa is known as NYC’s premier body sculpting center.
Now, you can finally achieve your weight loss goals without the risk or downtime of major bariatric surgery. The new, FDA-approved device, Orbera™, is a small gastric balloon that is gently placed into the stomach so you feel fuller longer and can practice portion control with greater success. Orbera™ is a non-surgical solution to help jump start your weight loss and maintain a healthier lifestyle.
Allergan's websites may ask your browser to store cookies, a small piece of data, on your computer or mobile device. A cookie can be used to enable a site to remember information that you previously input. It also helps deliver content-specific information to you and tracks how sections of websites are used. We may also use cookies to understand your preferences and tailor your access to your preferences. Your consent is required for Allergan to remember your user details and preferences over time. If you consent, check "I accept." You can withdraw your consent by changing your browser settings to erase cookies from your computer's hard drive, bock all cookies, or receive a warning before a cookie is stored. Please check your Internet browser's instructions to learn more about these functions. Your consent is voluntary; however, if you do not consent to cookies being installed on your browser, Allergan may not be able to provide you full access to or all the functionality of our websites.
1 July 2015: The CMA is considering whether it is or may be the case that this transaction has resulted in the creation of a relevant merger situation under the merger provisions of the Enterprise Act 2002 and, if so, whether the creation of that situation has resulted, or may be expected to result, in a substantial lessening of competition within any market or markets in the United Kingdom for goods or services.
×